JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis

Giovanni Barosi; Valentina Poletto; Margherita Massa; Rita Campanelli; Laura Villani; Elisa Bonetti; Gianluca Viarengo; Paolo Catarsi; Catherine Klersy; Vittorio Rosti

doi:10.1371/journal.pone.0059791

Loading metrics

Open Access

Peer-reviewed

Research Article

JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis

Giovanni Barosi ,

* E-mail: barosig@smatteo.pv.it

Affiliation Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Valentina Poletto,

Affiliation Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Margherita Massa,

Affiliation Biotechnology Research Area, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Rita Campanelli,

Affiliation Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Laura Villani,

Affiliation Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Elisa Bonetti,

Affiliation Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Gianluca Viarengo,

Affiliation Unit of Clinical Immunology, Immunohematology, and Transfusion Service, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Paolo Catarsi,

Affiliation Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Catherine Klersy,

Affiliation Service of Biometry and Statistics, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯
Vittorio Rosti

Affiliation Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
⨯

JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis

Giovanni Barosi,
Valentina Poletto,
Margherita Massa,
Rita Campanelli,
Laura Villani,
Elisa Bonetti,
Gianluca Viarengo,
Paolo Catarsi,
Catherine Klersy,
Vittorio Rosti

Published: March 26, 2013
https://doi.org/10.1371/journal.pone.0059791

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Homozygosity
Is the Subject Area "Homozygosity" applicable to this article?

Thanks for your feedback.
Variant genotypes
Is the Subject Area "Variant genotypes" applicable to this article?

Thanks for your feedback.
Heterozygosity
Is the Subject Area "Heterozygosity" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.
Cloning
Is the Subject Area "Cloning" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.